✦ LIBER ✦

Evaluation of survival data for chronic myelocytic leukemia

✍ Scribed by Joseph E. Sokal

Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 456 KB
Volume: 1
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830010414

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Another look at survival curves in chron

Another look at survival curves in chronic myelocytic leukemia

✍ H. D. Preisler; P. A. Reese 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

Erythropoiesis during an erythroblastic

Erythropoiesis during an erythroblastic transformation of chronic myelocytic leukemia

✍ Ronald Hoffman; Nicholas Dainiak; Victoria Floyd; A. Kim Ritchey; Eric Mazur 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

The requirements of erythropoiesis for erythropoietin were studied in a patient with Ph' chronic myelocytic leukemia who had undergone an erythroblastic transformation. Transfusions resulted in a suppression of erythropoiesis. Plasma clot culture studies indicated that both the CFU-E and BFU-E in th

Electron microscope cytochemical analysi

Electron microscope cytochemical analysis of chronic myelocytic leukemia: A case report

✍ Lora Weiselberg; Saul Teichberg; Vincent Vinciguerra; Philip Schulman; Daniel Bu 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 1 views

Comparison of busulfan and cyclophospham

Comparison of busulfan and cyclophosphamide in the treatment of chronic myelocytic leukemia

✍ David T. Kaung; Henry P. Close; Richard M. Whittington; Mary Ellen Patno 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB 👁 1 views

Porty-one patients with chronic myelocytic leukemia were treated with busulfan, 0.1 mg/kg/day, or cyclophosphamide, 2.0 mg/kg/day, orally for 8-12 weeks in a double-blind study. In the busulfan-treated group, there were 5 complete remissions, 10 partial remissions, 4 slight remissions, and no remiss

Assessment of evaluation criteria for su

Assessment of evaluation criteria for survival prediction from genomic data

✍ Hege M. Bøvelstad; Ørnulf Borgan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 1 views

## Abstract Survival prediction from high‐dimensional genomic data is dependent on a proper regularization method. With an increasing number of such methods proposed in the literature, comparative studies are called for and some have been performed. However, there is currently no consensus on which

Chronic myelocytic leukemia. Chromosome

Chronic myelocytic leukemia. Chromosome studies of a patient and his nonleukemic identical twin

✍ J. Bauke 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 1 views

T h e chromosome constitution of peripheral blood cells and bone marrow cells was studied in a 31-year-old man with chronic myelocytic leukemia a n d his normal identical twin. Evidence for their identity includes similar physical appearance, identical blood group antigens a n d serum factors, simil